Franco Fernández, Rafael2015-04-072015-04-072014-12-161662-5137https://hdl.handle.net/2445/64745As the title of the special issue indicates, controversy surrounds augmentation of brain cognition in humans. Lacking efficacious drugs for Alzheimer's disease (AD) and with many AD patients recruited for clinical trials that unfortunately do not provide the expected results, one wonders whether to test cognition enhancement strategies in individuals without symptoms of cognition decline. This opinion article presents the view that safe drugs and or dietary supplements should be tested worldwide in aged individuals under the control of a non-for-profit organization.3 p.application/pdfengcc-by (c) Franco Fernández, Rafael, 2014http://creativecommons.org/licenses/by/3.0/esMalaltia d'AlzheimerGenètica humanaVitamina CInhibidors de fosfodiesterasesAlzheimer's diseaseHuman geneticsVitamin CPhosphodiesterase Inhibitorsinfo:eu-repo/semantics/article6495212015-04-07info:eu-repo/semantics/openAccess25565993